Acuity Healthcare LP

DUBLIN, July 12, 2022 /PRNewswire/ -- The "Global Hospital Care Partnering 2015-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global Hospital Care Partnering 2015 to 2022 provides the full collection of Hospital Care disease deals signed between the world's pharmaceutical and biotechnology companies since 2015. Trends in Hospital Care partnering deals Financial deal terms for headline, upfront and royalty by stage of development Hospital Care partnering agreement structure Hospital Care partnering contract documents Top Hospital Care deals by value Most active Hospital Care dealmakers Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element. The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals. The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals. Global Hospital Care Partnering 2015 to 2022 includes: Trends in Hospital Care dealmaking in the biopharma industry since 2015 Access to headline, upfront, milestone and royalty data Access to hundreds of Hospital Care deal contract documents Comprehensive access to over 1200 Hospital Care deal records The leading Hospital Care deals by value since 2015 Most active Hospital Care dealmakers since 2015 Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in Hospital Care dealmaking 2.1. Introduction 2.2. Hospital Care partnering over the years 2.3. Hospital Care partnering by deal type 2.4. Hospital Care partnering by industry sector 2.5. Hospital Care partnering by stage of development 2.6. Hospital Care partnering by technology type 2.7. Hospital Care partnering by therapeutic indication Chapter 3 -Financial deal terms for Hospital Care partnering 3.1. Introduction 3.2. Disclosed financials terms for Hospital Care partnering 3.3. Hospital Care partnering headline values 3.4. Hospital Care deal upfront payments 3.5. Hospital Care deal milestone payments 3.6. Hospital Care royalty rates Chapter 4 - Leading Hospital Care deals and dealmakers 4.1. Introduction 4.2. Most active in Hospital Care partnering 4.3. List of most active dealmakers in Hospital Care 4.4. Top Hospital Care deals by value Chapter 5 - Hospital Care contract document directory 5.1. Introduction 5.2. Hospital Care partnering deals where contract document available Chapter 6 - Hospital Care dealmaking by therapeutic target 6.1. Introduction 6.2. Deals by Hospital Care therapeutic target Companies Mentioned 3D-Side 3D Systems 3M 3SBio 4WEB Medical 7 Hills Pharma 7D Surgical 11 Health and Technologies 111 A&E Medical AAP Implantate AG Aatru Medical Abbvie Abiomed Ab Medica Abram Scientific Absolute Antibody AbSorber Acacia Pharma Acacia Research Acare Medical Science Accelus Accenture Access Scientific Accord Healthcare Accuray AccuTec Blades Acelity Acell Acelrx Pharmaceuticals Acentrus Specialty Acerus ActLight Acuity Healthcare Acuna-Fombona AdaptHealth Adaptimmune ADAS 3D Medical Adeor Medical Adhezion Biomedical ADIENNE Pharma & Biotech Admedus Advanced Aesthetic Technologies Advanced Cooling Therapy Advanced Guidance Technologies Advanced IT Concepts Advanced Ultrasound Systems Advantage Medical Advanz Pharma AdventHealth Aerapy Aerobiotix Aesculap Aesthetic Management Partners Aesthetic Medical International Aethlon Medical Aetna Agadia Systems AgeX Therapeutics Agiliti AgNovos Healthcare Aguettant Aidoc Aiforia Technologies AirStrip Technologies AirXpanders Aitrics Akari Therapeutics Akers Biosciences Akumin ALASTIN Skincare Alfasigma Algeos AliMed AliveCor ALK-Abello Allegheny Technologies Allenex Allergan Allergan Aesthetics Alliance Medical Allied Centre for Medical Excellence Alliqua Biomedical Alloksys Life Sciences AlloSource Almirall Alnylam Pharmaceuticals Alpha Imaging Alphamedix Alphatec Spine Altan Pharma Altaris Capital Partners Altasciences Altitude International Alume Biosciences Alvarado Hospital Medical Center Alyzen Medical Physics Amag Pharmaceuticals Ambra Health Ambu Amedica Amedisys Amendia Amend Surgical American Academy of Orthopaedic Surgeons American College of Chest Physicians American Health Imaging American Medical Technologies American Society for Aesthetic Plastic Surgery American Well Amerinet AmerisourceBergen Amgen AMI Amicrobe AMNIOX Amomed Pharma Amplifire Amplyx Pharmaceuticals Ancestry Anelixis Therapeutics Anelto Angiodynamics Angion Biomedica Angsana Molecular & Diagnostics Anika Therapeutics Anita Tecnica ANP Technologies Antares Pharma Anthem Antibe Therapeutics Apex Physics Partners ApiFix Apollo Endosurgery Appalachian Regional Healthcare Apple Applied DNA Sciences Applimotion APR Medtech Aptevo Therapeutics Archer Capital Arch Therapeutics argenx Argon Medical Devices Aridea Solutions Aridis Pharmaceuticals Arjo Arkansas Childrens Hospital Armaghan Salamat Kish Armis Biopharma Armor Arsenal Medical Artegraft Arteriocyte Medical Systems Arthrex Arthrosurface ARxIUM Asahi Kasei Ascendum Ascension Ascension Saint Thomas Asensus Surgical ASICO AskAt Asklepios Group Aspen Surgical Products Assure Astarte Medical Astellas Pharma AstraZeneca Asys Athersys Atlas Lift Tech ATL Technology Atnahs Pharma Atos Medical Atricure For more information about this report visit Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

MECHANICSBURG, Pa., June 21, 2021 /PRNewswire/ -- Select Medical Corporation (NYSE: SEM) today announced that it has entered into a series of transactions that will result in the company operating seven new critical illness recovery hospitals, licensed as long-term acute care, and eight new outpatient clinics through acquisitions and new joint venture partnerships. The transactions are subject to regulatory approval and expected to close by Q3/Q4 2021. "We are excited to embark on these new joint ventures and acquisitions to bring world-class post-acute care to both existing and new markets across the country," said David Chernow, president and chief executive officer of Select Medical. "These deals underscore the focus and success of our strategic growth model to expand our continuum of care through partnerships with premier health care systems that share our mission to deliver the highest level of clinical and operational excellence to the patients, families and communities our hospitals serve." Critical Illness Recovery Hospitals Select Medical has signed definitive agreements to acquire Acuity Healthcare. Acuity Healthcare owns and operates four long-term acute care hospitals and one satellite serving regions in New Jersey and West Virginia. The acquisition also includes four joint venture partnerships with AtlantiCare, Mon Health, Virtua Health and physician partners. The five acquired hospitals will be rebranded as Select Specialty Hospitals. Each facility will remain in its current location in Atlantic City and Willingboro, NJ, and Morgantown, Wheeling and Weirton, WV. Select Medical and Northwest Healthcare, a subsidiary of Community Health Systems, have signed a joint venture partnership to acquire Curahealth Tucson, a 47-bed long-term acute care hospital. Under the agreement, Select Medical and Northwest Healthcare will relocate the hospital to Northwest Medical Center in September 2021. The hospital will be rebranded as Select Specialty Hospital – Tucson Northwest. Expanding its presence in Nashville, Select Medical has entered into a joint venture partnership with Ascension Saint Thomas to establish a new 30-bed critical illness recovery hospital inside Ascension's Saint Thomas Hospital West. It will be branded Select Specialty Hospital – Nashville West and be a satellite hospital to Select Specialty Hospital – Nashville, a 70-bed critical illness recovery hospital that has served the region since 1998. Scripps Health joined the existing joint venture partnership between Select Medical and UC San Diego Health in Select Medical's 110-bed critical illness recovery hospital, Select Specialty Hospital – San Diego, which became part of the company's national network in 2019. Outpatient Rehabilitation Select Medical signed a joint venture partnership to acquire an ownership interest and management services for eight HealthWorks Rehab & Fitness clinics in West Virginia. The deal also marks Select Medical's entrance into the state for outpatient physical therapy services. "Select Medical treats 82,000 patients a day across our post-acute care continuum. Since the outset of the COVID-19 pandemic, more than 16,000 patients requiring liberation from ventilators and extended specialty care as well as inpatient and outpatient rehabilitation have come through the doors of our hospitals, clinics and centers. The ability to extend that level of healthcare, quality and outcomes to new communities through these new joint venture partnerships is a privilege," said Chernow. About Select Medical Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics and occupational health centers in the United States. As of March 31, 2021, Select Medical operated 99 critical illness recovery hospitals in 28 states, 30 rehabilitation hospitals in 12 states, and 1,809 outpatient rehabilitation clinics in 37 states and the District of Columbia. Select Medical's joint venture subsidiary Concentra operated 519 occupational health centers in 41 states. At March 31, 2021, Select Medical had combined operations in 46 states and the District of Columbia and employed more than 48,000 people. For more information, visit . Company Codes: NYSE:SEM

Deal to Add Long-Term Acute Care Hospitals to Company's National Post-Acute Network [21-June-2021] MECHANICSBURG, Pa., June 21, 2021 /PRNewswire/ --Select Medical Corporation today announced it has signed a definitive agreement to acquire Charlotte, NC-based Acuity Healthcare. The purchase will include four long-term acute care hospitals and one satellite serving communities in New Jersey and West Virginia. The deal also includes the establishment of four joint venture (JV) partnerships with AtlantiCare, Mon Health, Virtua Health and physician partners. "This agreement represents Select Medical's continued focus to execute strategic joint ventures as part of its growth strategy," said Tom Mullin, executive vice president and chief operating officer of specialty hospitals at Select Medical. "Together, with our new partners, we look forward to serving the specialty care needs of chronic, critically ill patients in these emergent regions." Through the agreement, Select Medical's national network of critical illness recovery hospitals, licensed as long-term acute care, will expand to 104 locations. The Acuity hospitals to be acquired will be renamed Select Specialty Hospital and remain in current New Jersey and West Virginia locations. Select Specialty Hospital – Willingboro, NJ – Virtua Health JV partner Select Specialty Hospital – Atlantic City, NJ – AtlantiCare JV partner Select Specialty Hospital – Morgantown, WV – Mon Health JV partner Select Specialty Hospital – Weirton, WV – Physician JV partners Select Specialty Hospital – Wheeling, WV (Satellite Location) – Physician JV partners "The joint venture partnership with Select Medical brings the clinical excellence and best practices of the nation's No. 1 post-acute care provider to the regions we currently serve," said Ed Cooper, president and chief executive officer at Acuity Healthcare. Select Medical shares our common mission to build healthy communities and improve quality of life for the patients and families they serve. As the aging population continues to grow, the need for continued long-term acute care to treat chronic, critically ill patients has become an essential service and they are well-positioned to handle the future changes facing healthcare and the post-acute industry." The deal is expected to close in Q3 2021, subject to regulatory approval. About Acuity Healthcare Acuity Healthcare is an employee-owned (ESOP) long-term acute care hospital company (LTACH) founded in 2001 with headquarters in Charlotte, North Carolina. Acuity Healthcare currently owns and manages four LTACHs with five locations in New Jersey and West Virginia. Acuity is focused on the development and operation of LTACHs and the delivery of specialized care with improved outcomes. We offer quality care in a cost-effective manner to medically complex patients who require intensive hospital services for an extended length of stay. To learn more about Acuity Healthcare, please visit us at . About Select Medical Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics and occupational health centers in the United States. As of March 31, 2021, Select Medical operated 99 critical illness recovery hospitals in 28 states, 30 rehabilitation hospitals in 12 states, and 1,809 outpatient rehabilitation clinics in 37 states and the District of Columbia. Select Medical's joint venture subsidiary Concentra operated 519 occupational health centers in 41 states. At March 31, 2021, Select Medical had combined operations in 46 states and the District of Columbia and employed more than 48,000 people. For more information, visit . Company Codes: NYSE:SEM